Industry

DUBLIN–(BUSINESS WIRE)–The “Stents: Technologies and Global Markets 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027. The global market for … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Blockchain Technology in Healthcare Market” report has been added to ResearchAndMarkets.com’s offering. Blockchain technology in the healthcare market is being developed due to the growing incidence of data breaches. The development of unproductive healthcare database systems has tended to increase the demand for blockchain solutions in healthcare. Healthcare is on the verge … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Nutraceuticals, Carbon Capture, Lithium Metal Batteries, Self Healing Concrete, and e-Skin for Health Vitals Monitoring” report has been added to ResearchAndMarkets.com’s offering. The report features information on the use of anti-secretory supplements to treat gastrointestinal disorders during cancer and HIV therapy. It covers innovations based on the use of biodegradable … [Read more…]

SEOUL, South Korea–(BUSINESS WIRE)–DEXLEVO, an aesthetic medical device company, attended the international conference on cosmetic formation opening in Paris, IMCAS World Congress 2022 on 2022.06.03~06.05, and introduced the excellence and effectiveness of ‘GOURI’. IMCAS World Congress is one of the world’s top 3 cosmetic conferences, is an event where over 20,000 visitors from more than … [Read more…]

Australian approval follows recent trial approval by regulatory authorities in France MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that the initiation of a Proof of Concept (POC) … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–NeuroVasc Technologies, Inc. today announced that the first patient has been treated in its US IDE Clinical Trial, ENVI RCT – NeuroVasc Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke. This trial will evaluate the safety and efficacy of the NeuroVasc ENVI™-SR, a stent-retriever intended for the treatment of acute ischemic … [Read more…]

Children Ages 2 to <12 Experienced 94.8% Fewer Hereditary Angioedema (HAE) Attacks During Treatment with TAKHZYRO Over the 52-Week Treatment Period Compared to Baseline Late-Breaking Flash Talk Presentation of Phase 3 Data Highlights Positive, Clinically Meaningful Results in Children <6 Years, Where No Long-Term Prophylaxis Treatment (LTP) is Currently Approved Results are Consistent with the … [Read more…]

— Analysis to be Presented Showed Peanut Allergy Treatment with PALFORZIA was Associated with Improvements in Health-Related Quality of Life among Patients and Caregivers— —Additional Data to be Presented Suggested Increased Satisfaction Rates Associated with Convenience and Effectiveness of PALFORZIA Treatment— BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc., a Nestlé Health Science company developing pharmaceutical therapies to … [Read more…]

Acquisition complements Emerson’s software and technology portfolio and helps accelerate delivery of life-saving medicines ST. LOUIS–(BUSINESS WIRE)–Emerson (NYSE: EMR) today announced it has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to accelerate the speed to market for new therapies, drugs and vaccines. The acquisition builds on … [Read more…]

Merative will deliver industry-leading data and technology across the healthcare value chain SAN FRANCISCO–(BUSINESS WIRE)–Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, today announced that it has completed the acquisition of healthcare data and analytics assets that were part of IBM’s (NYSE: IBM) Watson Health business, previously announced in … [Read more…]